id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA_FRDOC_0001-32454,EPA,EPA_FRDOC_0001,"No-Migration Variance from Land Disposal Restrictions for Clean Harbors Lone Mountain, OK",Notice,,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,,2025-12-30T18:49:21Z,C1-2025-22553,0,0,09000064b910c3ea
EPA-HQ-OAR-2021-0329-0065,EPA,EPA-HQ-OAR-2021-0329,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Certification and Compliance Requirements for Nonroad Spark-Ignition Engines",Notice,Information Collection Request (ICR),2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,2026-01-29T04:59:59Z,2026-01-17T13:22:17Z,2025-23922,0,0,09000064b910c3e7
EPA-HQ-OPPT-2021-0728-0032,EPA,EPA-HQ-OPPT-2021-0728,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: TSCA Section 5 Premanufacture Review of New Chemical Substances and Significant New Use Rules for New and Existing Chemical Substances (Renewal)",Notice,Information Collection Request (ICR),2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,2026-01-30T04:59:59Z,2025-12-30T19:39:06Z,2025-23972,0,0,09000064b910c4eb
EPA-HQ-OLEM-2018-0646-0046,EPA,EPA-HQ-OLEM-2018-0646,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Safe Management of Recalled Airbags Rule",Notice,Information Collection Request (ICR),2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,2026-01-30T04:59:59Z,2025-12-30T19:16:12Z,2025-23973,0,0,09000064b910c3e6
EPA-HQ-OAR-2020-0657-0005,EPA,EPA-HQ-OAR-2020-0657,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: New Source Performance Standards for Kraft Pulp Mills",Notice,Information Collection Request (ICR),2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,2026-01-30T04:59:59Z,2025-12-30T19:28:24Z,2025-23966,0,0,09000064b910d14d
EPA-HQ-OAR-2022-0066-0004,EPA,EPA-HQ-OAR-2022-0066,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: New Source Performance Standards for Grain Elevators",Notice,Information Collection Request (ICR),2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,2026-01-30T04:59:59Z,2025-12-30T19:45:22Z,2025-23921,0,0,09000064b910c4ee
EPA-HQ-OPP-2020-0693-0026,EPA,EPA-HQ-OPP-2020-0693,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Pesticide Data Call-Ins",Notice,,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,2026-01-30T04:59:59Z,2025-12-31T00:15:34Z,2025-23967,0,0,09000064b910c441
FDA-2025-N-1928-0026,FDA,FDA-2025-N-1928,GRAS Notice (GRN) 1250 - Alternansucrase enzyme preparation produced by Escherichia coli,Notice,General Notice,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,,2025-12-30T23:09:02Z,,0,0,09000064b910d339
FDA-2025-N-1928-0033,FDA,FDA-2025-N-1928,GRAS Notice (GRN) 1278 - Lactiplantibacillus plantarum CGMCC 6312,Notice,General Notice,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,,2025-12-30T23:17:03Z,,0,0,09000064b910d360
FDA-2025-N-1928-0031,FDA,FDA-2025-N-1928,GRAS Notice (GRN) 1273 - Lacto-N-tetraose,Notice,General Notice,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,,2025-12-30T23:15:50Z,,0,0,09000064b910d33f
FDA-2025-N-1928-0032,FDA,FDA-2025-N-1928,GRAS Notice (GRN) 1276 - Cellulase enzyme preparation produced by Trichoderma reesei,Notice,General Notice,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,,2025-12-30T23:16:15Z,,0,0,09000064b910d340
FDA-2025-N-1928-0029,FDA,FDA-2025-N-1928,GRAS Notice GRN 1269 - Modified monellin preparation produced by Komagataella phaffii CBS 150005 - Part 1 of 2,Notice,General Notice,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,,2025-12-30T23:12:21Z,,0,0,09000064b910d33d
FDA-2025-N-1927-0099,FDA,FDA-2025-N-1927,GRAS Notice (GRN) 1226 - Orange (Citrus sinensis) extract - amendments,Notice,General Notice,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,,2025-12-30T23:07:43Z,,0,0,09000064b910d2f3
FDA-2025-N-1928-0027,FDA,FDA-2025-N-1928,GRAS Notice (GRN) 1266 - Wheat fiber extract from wheat (Triticumaestivum),Notice,General Notice,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,,2025-12-30T23:10:03Z,,0,0,09000064b910d33a
FDA-2025-N-1928-0028,FDA,FDA-2025-N-1928,GRAS Notice (GRN) 1267 - Sunflower lecithin,Notice,General Notice,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,,2025-12-30T23:10:59Z,,0,0,09000064b910d33b
FDA-2025-N-1928-0030,FDA,FDA-2025-N-1928,GRAS Notice GRN 1269 - Modified monellin preparation produced by Komagataella phaffii CBS 150005 - Part 2 of 2,Notice,General Notice,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,,2025-12-30T23:15:10Z,,0,0,09000064b910d33e
FWS-R8-ES-2025-0407-0001,FWS,FWS-R8-ES-2025-0407,"Receipt of Incidental Take Permit Application and Proposed  Habitat Conservation Plan for Piraeus Point Project, City of Encinitas,  CA; Categorical Exclusion",Notice,,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,2026-01-30T04:59:59Z,2026-01-31T13:12:40Z,2025-23971,0,0,09000064b910c358
USDA_FRDOC_0001-3252,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,,2025-12-30T18:50:04Z,2025-24006,0,0,09000064b910d1dd
USDA_FRDOC_0001-3250,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,,2025-12-30T18:49:32Z,2025-23982,0,0,09000064b910c448
USDA_FRDOC_0001-3251,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2025-12-30T05:00:00Z,2025,12,2025-12-30T05:00:00Z,,2025-12-30T18:50:02Z,2025-23981,0,0,09000064b910d199
EPA-R09-OAR-2025-4149-0001,EPA,EPA-R09-OAR-2025-4149,Receipt of Tribal Minor NSR Permit Application for Morongo Casino Cogeneration Facility,Notice,,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,,2025-12-30T04:48:22Z,,0,0,09000064b910c58d
FDA-2025-N-7022-0001,FDA,FDA-2025-N-7022,Roundtable on Premarket Tobacco Application Submissions for Electronic Nicotine Delivery Systems Products; Notice of Meeting; Establishment of a Public Docket; Request for Comments,Notice,Request for Comments,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-03-13T03:59:59Z,2026-02-14T13:17:33Z,2025-23851,1,0,09000064b910a287
FDA-2024-E-1284-0008,FDA,FDA-2024-E-1284,Determination of Regulatory Review Period for Purposes of Patent Extension; ADZYNMA,Notice,Determinations,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-02-28T04:59:59Z,2025-12-29T19:32:46Z,2025-23864,0,0,09000064b910a420
FDA-2024-E-1293-0006,FDA,FDA-2024-E-1293,Determination of Regulatory Review Period for Purposes of Patent Extension; ZELSUVMI,Notice,Determinations,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-02-28T04:59:59Z,2026-02-28T10:00:12Z,2025-23868,0,0,09000064b910a4a8
FDA-2024-E-1287-0007,FDA,FDA-2024-E-1287,Determination of Regulatory Review Period for Purposes of Patent Extension; ADZYNMA,Notice,Determinations,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-02-28T04:59:59Z,2025-12-29T19:37:21Z,2025-23864,0,0,09000064b910aaad
FDA-2024-E-1286-0006,FDA,FDA-2024-E-1286,Determination of Regulatory Review Period for Purposes of Patent Extension; ADZYNMA,Notice,Determinations,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-02-28T04:59:59Z,2025-12-29T19:35:54Z,2025-23864,0,0,09000064b910aaac
FDA-2025-N-6971-0001,FDA,FDA-2025-N-6971,Authorization of Emergency Use for Two Animal Drugs for the Treatment of New World Screwworm; Availability,Notice,Announcement,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,,2025-12-29T20:06:23Z,2025-23914,0,0,09000064b910a2c5
FDA-2024-E-3865-0007,FDA,FDA-2024-E-3865,Determination of Regulatory Review Period for Purposes of Patent Extension; OJEMDA,Notice,Determinations,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-02-28T04:59:59Z,2025-12-29T19:57:00Z,2025-23867,0,0,09000064b910a301
FDA-2025-N-4684-0001,FDA,FDA-2025-N-4684,"Egis Pharmaceuticals Limited, et.al.; Proposal To Withdraw Approval of Three Abbreviated New Drug Applications; Opportunity for a Hearing",Notice,Withdrawal,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-02-28T04:59:59Z,2025-12-29T19:49:40Z,2025-23870,0,0,09000064b910a3d3
FDA-2025-N-3656-0002,FDA,FDA-2025-N-3656,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practices for Positron Emission Tomography Drugs,Notice,30 Day Proposed Information Collection,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-01-29T04:59:59Z,2026-01-31T13:12:34Z,2025-23859,0,0,09000064b910a46c
FDA-2025-P-5560-0023,FDA,FDA-2025-P-5560,Medical Devices; Exemption From Premarket Notification: Radiology Computer-Aided Detection and/or Diagnosis Devices and Computer-Aided Triage and Notification Devices,Notice,Announcement,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-02-28T04:59:59Z,2026-02-28T10:00:12Z,2025-23901,0,0,09000064b910a2ff
FDA-2024-E-1285-0007,FDA,FDA-2024-E-1285,Determination of Regulatory Review Period for Purposes of Patent Extension; ADZYNMA,Notice,Determinations,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-02-28T04:59:59Z,2025-12-29T19:34:39Z,2025-23864,0,0,09000064b91077dc
FDA-2024-E-1288-0007,FDA,FDA-2024-E-1288,Determination of Regulatory Review Period for Purposes of Patent Extension; ADZYNMA,Notice,Determinations,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-02-28T04:59:59Z,2025-12-29T19:39:03Z,2025-23864,0,0,09000064b910acd7
FDA-2025-E-0917-0006,FDA,FDA-2025-E-0917,Determination of Regulatory Review Period for Purposes of Patent Extension; ALHEMO,Notice,Determinations,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-02-28T04:59:59Z,2025-12-29T20:38:53Z,2025-23863,0,0,09000064b9106d07
FDA-2025-N-6896-0001,FDA,FDA-2025-N-6896,Over-the-Counter Monograph Drug User Fee Amendments—OTC Monograph Order Request Fee Rates for Fiscal Year 2026,Notice,Announcement,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,,2025-12-29T19:44:43Z,2025-23852,0,0,09000064b910a41f
FDA-2023-E-3236-0006,FDA,FDA-2023-E-3236,Determination of Regulatory Review Period for Purposes of Patent Extension; LEQEMBI,Notice,Determinations,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-02-28T04:59:59Z,2025-12-29T20:09:09Z,2025-23865,0,0,09000064b910a288
FDA-2025-E-0923-0006,FDA,FDA-2025-E-0923,Determination of Regulatory Review Period for Purposes of Patent Extension; ROMVIMZA,Notice,Determinations,2025-12-29T05:00:00Z,2025,12,2025-12-29T05:00:00Z,2026-02-28T04:59:59Z,2025-12-29T19:54:00Z,2025-23862,0,0,09000064b910a397
FDA-2025-N-1210-0002,FDA,FDA-2025-N-1210,Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Postmarket Surveillance of Medical Devices,Notice,30 Day Proposed Information Collection,2025-12-23T05:00:00Z,2025,12,2025-12-23T05:00:00Z,2026-01-22T04:59:59Z,2026-01-24T13:18:31Z,2025-23630,0,0,09000064b91065e6
FDA-2023-D-2204-0005,FDA,FDA-2023-D-2204,"Formal Dispute Resolution and Administrative Hearings of Final Administrative Orders Under Section 505G of the Federal Food, Drug, and Cosmetic Act; Guidance for Industry; Availability",Notice,Notice of Availability,2025-12-23T05:00:00Z,2025,12,2025-12-23T05:00:00Z,,2025-12-23T18:49:14Z,2025-23707,0,0,09000064b91065e7
FWS-R4-ES-2025-1067-0001,FWS,FWS-R4-ES-2025-1067,"Receipt of Incidental Take Permit Application and Proposed Habitat Conservation Plan for the Sand Skink and Blue-Tailed Mole Skink; Osceola County, FL; Categorical Exclusion",Notice,,2025-12-23T05:00:00Z,2025,12,2025-12-23T05:00:00Z,2026-01-23T04:59:59Z,2026-01-24T13:18:34Z,2025-23647,0,0,09000064b9107ae1
FWS-HQ-IA-2025-0935-0001,FWS,FWS-HQ-IA-2025-0935,Agency Information Collection Activities; Federal Fish and  Wildlife Permit Applications and Reports--Management Authority,Notice,,2025-12-23T05:00:00Z,2025,12,2025-12-23T05:00:00Z,2026-02-24T04:59:59Z,2026-02-24T10:00:11Z,2025-23694,0,0,09000064b9107a7e
USDA_FRDOC_0001-3247,USDA,USDA_FRDOC_0001,Request for Information: Refined Sugar; Correction,Notice,,2025-12-22T05:00:00Z,2025,12,2025-12-22T05:00:00Z,,2025-12-22T17:45:06Z,2025-23604,0,0,09000064b90fd296
USDA_FRDOC_0001-3248,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2025-12-22T05:00:00Z,2025,12,2025-12-22T05:00:00Z,,2025-12-22T17:45:35Z,2025-23631,0,0,09000064b90fd3fd
EPA_FRDOC_0001-32449,EPA,EPA_FRDOC_0001,"Environmental Impact Statements; Availability, etc.",Notice,,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T17:16:18Z,2025-23436,0,0,09000064b90f52ae
EPA-HQ-OPP-2025-0029-0003,EPA,EPA-HQ-OPP-2025-0029,Cancellation Order for Certain Pesticide Registrations and/or Amendments to Terminate Uses,Notice,,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:21:35Z,2025-23444,0,0,09000064b90f48af
FDA-2024-N-4731-0003,FDA,FDA-2024-N-4731,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:08:09Z,2025-23483,0,0,09000064b90f0496
FDA-2025-N-0383-0006,FDA,FDA-2025-N-0383,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:14:36Z,2025-23483,0,0,09000064b90f049b
FDA-2025-N-6076-0001,FDA,FDA-2025-N-6076,Agency Information Collection Activities; Proposed Collection; Comment Request; Required Warnings for Cigarette Packages and Advertisements,Notice,60 Day Proposed Information Collection,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,2026-02-18T04:59:59Z,2026-01-24T13:18:20Z,2025-23474,0,0,09000064b90f519a
FDA-2024-N-5468-0010,FDA,FDA-2024-N-5468,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:09:54Z,2025-23483,0,0,09000064b90f0498
FDA-2025-P-1562-0004,FDA,FDA-2025-P-1562,"Determination That DEXCHLORPHENIRAMINE MALEATE (Dexchlorpheniramine Maleate, Oral Syrup, 2 Milligrams/5 Milliliters) Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T19:43:25Z,2025-23419,0,0,09000064b90f5231
FDA-2025-N-0338-0004,FDA,FDA-2025-N-0338,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:45:55Z,2025-23483,0,0,09000064b90f5736
FDA-2025-N-0082-0009,FDA,FDA-2025-N-0082,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:50:27Z,2025-23483,0,0,09000064b90f573c
FDA-2025-P-1304-0004,FDA,FDA-2025-P-1304,"Determination That EFFEXOR XR (Venlafaxine Hydrochloride) Extended- Release Capsule, 100 Milligrams, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T21:21:26Z,2025-23408,0,0,09000064b90f5195
FDA-2024-N-5603-0004,FDA,FDA-2024-N-5603,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:06:25Z,2025-23483,0,0,09000064b90f51e3
FDA-2024-N-5234-0003,FDA,FDA-2024-N-5234,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:11:44Z,2025-23483,0,0,09000064b90f0499
FDA-2025-N-0123-0006,FDA,FDA-2025-N-0123,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:13:18Z,2025-23483,0,0,09000064b90f049a
FDA-2025-N-4683-0001,FDA,FDA-2025-N-4683,Issuance of Priority Review Voucher; Rare Pediatric Disease Product; FORZINITY (Elamipretide),Notice,Announcement,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T19:35:42Z,2025-23409,0,0,09000064b90f5277
FDA-2023-D-5021-0018,FDA,FDA-2023-D-5021,Processes and Practices Applicable to Bioresearch Monitoring Inspections; Guidance for Industry; Availability,Notice,Notice of Availability,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:54:43Z,2025-23404,0,0,09000064b90f519d
FDA-2025-N-0183-0005,FDA,FDA-2025-N-0183,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:48:14Z,2025-23483,0,0,09000064b90f573a
FDA-2025-N-0349-0006,FDA,FDA-2025-N-0349,Agency Information Collection Activities; Announcement of Office of Management and Budget Approvals,Notice,Notice of Approval,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:49:25Z,2025-23483,0,0,09000064b90f573b
FDA-2025-N-4682-0001,FDA,FDA-2025-N-4682,"Notice of Approval of Product Under Voucher: Rare Pediatric Disease Priority Review Voucher; KEYTRUDA
QLEX (pembrolizumab and berahyaluronidase alfa-pmph)",Notice,Notice of Approval,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,,2025-12-19T20:02:51Z,2025-23410,0,0,09000064b90f51e4
EPA-HQ-OAR-2022-0070-0005,EPA,EPA-HQ-OAR-2022-0070,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: New Source Performance Standards for Flexible Vinyl and Urethane Coating and Printing",Notice,Information Collection Request (ICR),2025-12-18T05:00:00Z,2025,12,2025-12-18T05:00:00Z,2026-01-21T04:59:59Z,2025-12-18T18:55:30Z,2025-23271,0,0,09000064b90ee7f8
EPA-HQ-OAR-2022-0021-0005,EPA,EPA-HQ-OAR-2022-0021,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: National Emission Standards for Hazardous Air Pollutants for Secondary Aluminum Production",Notice,Information Collection Request (ICR),2025-12-18T05:00:00Z,2025,12,2025-12-18T05:00:00Z,2026-01-21T04:59:59Z,2025-12-18T18:50:33Z,2025-23286,0,0,09000064b90ee844
EPA-HQ-OW-2002-0070-0003,EPA,EPA-HQ-OW-2002-0070,"Federal Register of September 27, 2001 [66 FR 49381] [FRL-7068-4]",Notice,Request for Comments,2025-12-18T05:00:00Z,2025,12,2025-12-18T05:00:00Z,2002-01-12T04:59:59Z,2025-12-19T10:00:17Z,01–24193,0,0,09000064b90f373c
FDA-2023-D-4395-0033,FDA,FDA-2023-D-4395,Use of Real-World Evidence To Support Regulatory Decision-Making for Medical Devices; Guidance for Industry and Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2025-12-18T05:00:00Z,2025,12,,,2025-12-18T18:40:06Z,2025-23252,0,0,09000064b90ee7f9
FDA-2025-D-2246-0001,FDA,FDA-2025-D-2246,Questions and Answers Regarding Mandatory Cosmetics Recalls: Draft Guidance for Industry; Availability,Notice,Notice of Availability,2025-12-18T05:00:00Z,2025,12,,,2025-12-18T18:30:54Z,2025-23249,0,0,09000064b90eed0c
USDA_FRDOC_0001-3246,USDA,USDA_FRDOC_0001,Performance Review Board Members,Notice,,2025-12-18T05:00:00Z,2025,12,2025-12-18T05:00:00Z,,2025-12-18T17:24:41Z,2025-23255,0,0,09000064b90ee7fd
USDA_FRDOC_0001-3245,USDA,USDA_FRDOC_0001,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2025-12-17T05:00:00Z,2025,12,2025-12-17T05:00:00Z,,2025-12-17T17:21:33Z,2025-23114,0,0,09000064b90ea99e
EPA-HQ-OPP-2025-0026-0010,EPA,EPA-HQ-OPP-2025-0026,Pesticide Product Registration: Applications for New Uses October 2025,Notice,,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,2026-01-16T04:59:59Z,2025-12-17T10:00:30Z,2025-22932,0,0,09000064b90da716
EPA-HQ-OPP-2025-2400-0001,EPA,EPA-HQ-OPP-2025-2400,Pesticide Product Registration: Applications for New Active Ingredients October 2025,Notice,,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,2026-01-16T04:59:59Z,2026-01-17T13:21:35Z,2025-22935,0,0,09000064b90d382a
EPA-HQ-OPP-2025-0024-0004,EPA,EPA-HQ-OPP-2025-0024,Pesticide Product Registration: Applications for New Active Ingredients October 2025,Notice,,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,,2025-12-17T02:18:41Z,2025-22935,0,0,09000064b90da748
EPA-HQ-OPP-2025-2566-0001,EPA,EPA-HQ-OPP-2025-2566,Pesticide Product Registration: Applications for New Active Ingredients October 2025,Notice,,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,2026-01-16T04:59:59Z,2025-12-16T21:37:49Z,2025-22935,0,0,09000064b90d3829
EPA-HQ-OPP-2025-2565-0001,EPA,EPA-HQ-OPP-2025-2565,Pesticide Product Registration: Applications for New Uses October 2025,Notice,,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,2026-01-16T04:59:59Z,2025-12-16T19:22:53Z,2025-22932,0,0,09000064b90dc7cc
FDA-2021-D-0368-0012,FDA,FDA-2021-D-0368,"Investigator Responsibilities—Safety Reporting for Investigational Drugs and Devices; Guidance for Investigators, Industry, and Institutional Review Boards; Availability",Notice,Notice of Availability,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,,2025-12-16T18:17:17Z,2025-22869,0,0,09000064b90da8c2
FDA-2020-D-2099-0012,FDA,FDA-2020-D-2099,"Sponsor Responsibilities—Safety Reporting Requirements and Safety Assessment for Investigational New
Drug Application and Bioavailability/ Bioequivalence Studies; Guidance for Industry; Availability",Notice,Notice of Availability,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,,2025-12-16T18:44:45Z,2025-22870,0,0,09000064b90da7e0
EPA-HQ-OPP-2017-0720-0064,EPA,EPA-HQ-OPP-2017-0720,Pesticide Registration Review: Draft Human Health and/or Ecological Risk Assessment for Metrafenone,Notice,,2025-12-15T05:00:00Z,2025,12,,,2025-12-15T21:41:54Z,2025-22811,0,0,09000064b90d32d3
EPA-HQ-OPP-2020-0032-0019,EPA,EPA-HQ-OPP-2020-0032,Pesticide Registration Review: Draft Human Health and/or Ecological Risk Assessment for Metrafenone,Notice,,2025-12-15T05:00:00Z,2025,12,2025-12-15T05:00:00Z,2026-02-14T04:59:59Z,2026-02-14T13:16:56Z,2025-22811,0,0,09000064b90d0baa
EPA-HQ-OPP-2021-0749-0015,EPA,EPA-HQ-OPP-2021-0749,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Foreign Purchaser Acknowledgement Statement of Unregistered Pesticides",Notice,,2025-12-15T05:00:00Z,2025,12,2025-12-15T05:00:00Z,2026-02-24T04:59:59Z,2026-02-06T00:48:03Z,2025-22741,0,0,09000064b90d33db
FWS-HQ-ES-2025-0613-0001,FWS,FWS-HQ-ES-2025-0613,Agency Information Collection Activities; Approval Procedures for Incidental Harassment Authorizations of Marine Mammals,Notice,,2025-12-15T05:00:00Z,2025,12,2025-12-15T05:00:00Z,2026-02-14T04:59:59Z,2026-02-14T13:16:56Z,2025-22770,0,0,09000064b90d0b21
EPA-HQ-OPP-2025-0049-0012,EPA,EPA-HQ-OPP-2025-0049,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Bilingual Pesticide Labeling Tracking",Notice,Information Collection Request (ICR),2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,2026-01-13T04:59:59Z,2026-01-17T13:21:29Z,2025-22589,0,0,09000064b90c85ae
EPA_FRDOC_0001-32433,EPA,EPA_FRDOC_0001,"Environmental Impact Statements; Availability, etc.",Notice,,2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,,2025-12-12T17:24:03Z,2025-22652,0,0,09000064b90c8692
FDA-2024-P-2952-0006,FDA,FDA-2024-P-2952,"Determination That LUNELLE (Estradiol Cypionate and Medroxyprogesterone Acetate) Injectable, 5 Milligrams/0.5 Milliliter and 25 Milligrams/0.5 Milliliter, Was Not Withdrawn From Sale for Reasons of
Safety or Effectiveness",Notice,Determinations,2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,,2025-12-12T22:12:49Z,2025-22680,0,0,09000064b90cb51b
FDA-2025-N-6494-0001,FDA,FDA-2025-N-6494,Amending Over-the-Counter Monograph M020: Sunscreen Drug Products for Over-the-Counter Human Use,Notice,Notice of Availability,2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,2026-01-27T04:59:59Z,2026-01-31T13:11:51Z,2025-22649,0,0,09000064b90c85ec
FDA-2025-N-6077-0001,FDA,FDA-2025-N-6077,"Pfizer Inc., U.S. Agent for King Pharmaceuticals LLC, et al.; Withdrawal of Approval of 20 Abbreviated New Drug Applications",Notice,Withdrawal,2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,,2025-12-12T19:37:48Z,2025-22683,0,0,09000064b90c8624
FDA-2020-P-1617-0005,FDA,FDA-2020-P-1617,"Determination That BACTROBAN (Mupirocin) Nasal Ointment, 2%, Was Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,,2025-12-12T19:43:45Z,2025-22682,0,0,09000064b90c85b0
FDA-2025-N-4732-0001,FDA,FDA-2025-N-4732,"Determination That ZANTAC (Ranitidine Hydrochloride) Injection, Equivalent to 25 Milligrams Base/
Milliliter, Has Not Been Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,,2025-12-12T19:55:43Z,2025-22676,0,0,09000064b90c85aa
FDA-2025-N-4734-0001,FDA,FDA-2025-N-4734,"Determination That DEMEROL (Meperidine Hydrochloride) Tablet, 100 Milligrams, and Other Drug Products
Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness",Notice,Determinations,2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,,2025-12-12T19:21:36Z,2025-22681,0,0,09000064b90c8657
FDA-2025-N-5997-0001,FDA,FDA-2025-N-5997,Biosimilar User Fee Act; Stakeholder Consultation Meetings on Biosimilar User Fee Act Reauthorization; Request for Notification of Stakeholder Intention To Participate,Notice,General Notice,2025-12-12T05:00:00Z,2025,12,2025-12-12T05:00:00Z,,2025-12-13T00:47:14Z,2025-22619,0,0,09000064b90c85ad
EPA_FRDOC_0001-32426,EPA,EPA_FRDOC_0001,Performance Review Board Members,Notice,,2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,,2025-12-11T17:19:07Z,2025-22520,0,0,09000064b90c5580
EPA_FRDOC_0001-32421,EPA,EPA_FRDOC_0001,"Charter Amendments, Establishments, Renewals and Terminations: Farm, Ranch, and Rural Communities Advisory Committee",Notice,,2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,,2025-12-11T17:18:55Z,2025-22561,0,0,09000064b90c30e6
EPA-HQ-OPP-2017-0720-0063,EPA,EPA-HQ-OPP-2017-0720,Pesticide Registration Review: Pesticide Dockets Opened for Review and Comment,Notice,,2025-12-11T05:00:00Z,2025,12,,,2025-12-12T02:43:13Z,2025-22514,0,0,09000064b90c5532
EPA-HQ-OPP-2025-0018-0001,EPA,EPA-HQ-OPP-2025-0018,Pesticide Registration Review: Pesticide Dockets Opened for Review and Comment,Notice,,2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,2026-02-10T04:59:59Z,2026-02-14T13:16:44Z,2025-22514,0,0,09000064b90c1dff
EPA-HQ-OLEM-2018-0102-0011,EPA,EPA-HQ-OLEM-2018-0102,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: RCRA Expanded Public Participation",Notice,Information Collection Request (ICR),2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,2026-02-10T04:59:59Z,2025-12-11T18:26:32Z,2025-22528,0,0,09000064b90c560e
EPA-HQ-SFUND-2006-0361-0031,EPA,EPA-HQ-SFUND-2006-0361,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Trade Secret Claims for Community Right-to-Know and Emergency Planning (Renewal)",Notice,Information Collection Request (ICR),2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,2026-02-10T04:59:59Z,2026-01-31T13:11:45Z,2025-22527,0,0,09000064b90c3069
EPA-HQ-OLEM-2018-0013-0013,EPA,EPA-HQ-OLEM-2018-0013,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Revisions to the RCRA Definition of Solid Waste",Notice,Information Collection Request (ICR),2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,2026-02-10T04:59:59Z,2026-02-14T13:16:49Z,2025-22529,0,0,09000064b90c557d
EPA-HQ-OPP-2024-0218-0001,EPA,EPA-HQ-OPP-2024-0218,Pesticide Registration Review: Pesticide Dockets Opened for Review and Comment,Notice,,2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,2026-02-10T04:59:59Z,2025-12-12T03:38:05Z,,0,0,09000064b90c757a
FDA-2025-N-6743-0001,FDA,FDA-2025-N-6743,Food and Drug Administration Expert Panel on Testosterone Replacement Therapy for Men; Request for Information,Notice,Requests for Information (RFI),2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,2026-02-10T04:59:59Z,2026-02-20T20:29:54Z,2025-22466,0,0,09000064b90c309f
FDA-2024-E-1291-0006,FDA,FDA-2024-E-1291,Determination of Regulatory Review Period for Purposes of Patent Extension; FILSUVEZ,Notice,Determinations,2025-12-10T05:00:00Z,2025,12,2025-12-10T05:00:00Z,2026-02-10T04:59:59Z,2026-02-07T13:13:03Z,2025-22380,0,0,09000064b90c192e
FDA-2024-E-1292-0006,FDA,FDA-2024-E-1292,Determination of Regulatory Review Period for Purposes of Patent Extension; FILSUVEZ,Notice,Determinations,2025-12-10T05:00:00Z,2025,12,2025-12-10T05:00:00Z,2026-02-10T04:59:59Z,2026-02-07T13:13:03Z,2025-22380,0,0,09000064b90c192f
FDA-2024-E-1290-0006,FDA,FDA-2024-E-1290,Determination of Regulatory Review Period for Purposes of Patent Extension; FILSUVEZ,Notice,Determinations,2025-12-10T05:00:00Z,2025,12,2025-12-10T05:00:00Z,2026-02-10T04:59:59Z,2026-02-07T13:13:03Z,2025-22380,0,0,09000064b90c167a